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Background: Previous studies have used electrical neuromuscular stimulation as a physical
training method in patients with severe COPD. We introduce the use of the more tolerable
magnetic stimulation for the same purpose, investigating the effectiveness of an eight-week
protocol.
Methods: Eighteen patients with severe COPD were randomly assigned to a magnetic stimula-
tion training protocol, nZ 10, FEV1Z 30% (SD: 7) or to parallel clinical monitoring, control
group, nZ 8, FEV1Z 35% (SD: 8). During eight weeks, patients were stimulated for 15 min
on each quadriceps femoris, three times per week. Quadriceps muscle strength and endurance
measurements, quality-of-life questionnaires (SF36, SGRQ) and a six-minute walking test were
all carried out before and after the training period in the stimulated and control subjects.
Results: All patients completed the training with increasing intensity of stimulation, displaying
a significant improvement in voluntary quadriceps strength (17.5% of the baseline value) and
exercise capacity, with a mean increase of 23 m in the six-minute walking test. The question-
naire scores showed greater increases in quality-of-life scores in the trained subjects
compared to the controls, particularly in the physical function areas: mean increments in
SF36 in ‘‘physical function’’: þ26, ‘‘role limitations due to physical problems’’: þ40 and
‘‘vitality’’: þ17.5, while þ13, 4 and þ1, respectively in controls. Saint George’s ‘‘Activity’’
score improved by 19.6 points, for 11.5 in controls.rant and the ENIGMA project. (European Network for Investigating the Global Mechanisms of Muscle
n Grant).
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238 V. Bustamante et al.Conclusions: In COPD patients who are limited due to dyspnoea, magnetic neuromuscular stim-
ulation of the quadriceps constitutes a feasible training method for the lower limbs, with posi-
tive effects on the muscle function, effort capacity and perception areas.
ª 2009 Elsevier Ltd. All rights reserved.Introduction
Atrophy and dysfunction of the striated skeletal muscula-
ture lead to reduced exercise capacity, impaired quality of
life and increased mortality in patients with chronic
obstructive pulmonary disease (COPD).1,2 In a high propor-
tion of COPD patients, in spite of their extremely abnormal
respiratory function, it may be the sensation of muscular
fatigue, rather than the dyspnoea, that is first to limit
exercise capacity.3,4 A great deal of evidence exists as to
the serious dysfunction of the quadriceps muscle in COPD,
with loss of type I fibres and reduced oxidative capacity,
phenomena that have been linked to impaired quality
of life, reduced exercise capacity and increased use of
healthcare resources.5,6 The quadriceps, as the subject
of standardized, routine muscle function measurements
such as maximal voluntary contraction or supramaximal
magnetic twitch, has become an indicator of the condition
of the musculature of the lower limbs.7,8
High-intensity exercise of the lower limbs, encom-
passed within what is known as ‘‘respiratory rehabilita-
tion,’’ is accepted as a treatment option with grade A
evidence.9,10 However, in severe COPD, training, although
beneficial, is not easily feasible and fully accomplishable,
due to the fact that an effort-overload is required from
the patient. In patients who are beyond this ‘‘window of
opportunity for rehabilitation,’’ interval training, Heliox
or oxygen supply and other strategies have been trialled,
in an attempt to make the most of their cardio-respiratory
reserves.11
Another alternative that has been raised is neuromus-
cular stimulation of the lower extremities, with positive
results having been obtained using electrical stimulation,
especially in more severe or muscularly-compromised COPD
patients,12e16 while simultaneously inducing minimal car-
dio-respiratory overload.17 Although effective for
increasing muscle strength, electrical stimulation may also
produce some painful sensations, which, in selected
subjects, may prevent the stimulus from being applied to
a sufficient degree in order to achieve maximal activa-
tion.18,19 Magnetic stimulation bypasses this limitation by
producing the stimulus at a deep level, thus avoiding the
skin sensation; for this reason it is currently replacing
electrical stimulation in diagnostic use.7 In recent years
equipment has become more complex, now including the
option of repetitive stimulation, which is necessary for
more complex measurements such as muscular fatigue20 or
to act on the muscle as a form of sustained stimulation
training. Previous experience in our group included the
evaluation of a Medtronic Magpro device with a refrigerated
circular MCF125 coil,21 where the contraction effect
measured after its application to the muscle bulk, was
comparable to the response to full femoral nerve activation
by standard supramaximal quadriceps twitch.8 In a selected
group of patients we also could contribute data on changein fibre types and redox balance after repetitive stimula-
tion.22 After establishing its suitability for a training
protocol, we decided to apply it to stable, COPD outpa-
tients to investigate the hypothesis of its feasibility as
a means for respiratory rehabilitation (RR), testing effec-
tivity by direct outcomes of muscle strength and endur-
ance, and by secondary rehabilitation aimed variables as
are exercise capacity and quality of life.
Methods
Study type
Randomized controlled clinical trial with the aim of eval-
uating an eight-week protocol of repetitive magnetic
stimulation (rMS) of the quadriceps muscle in COPD
patients. The outcomes to be assessed were parameters
relating to quadriceps muscle function, effort capacity (six-
minute walk distance, 6MWD) and quality of life.
Patients
Eighteen severe COPD patients, with FEV1< 50% (GOLD
stages IIIeIV) and habitual dyspnoea of at least grade II
according to the MRC scale23 were recruited on an outpa-
tient basis from hospital-dependent outpatient clinics.
Exclusion criteria were any changes in treatment during the
four months preceding the trial, and the presence of heart
pacemakers. Comorbidity was taken into account on an
individual basis, especially with regard to diseases of the
locomotive or cardiovascular systems or neurological
disease, as well as treatments that might interfere with
implementation of the protocol or with the evaluation of
functional outcomes. No participants in previous rehabili-
tation programs were accepted.
All patients were Caucasian, male and were exclusively
on inhaled medication (long-acting beta2-agonists, anti-
cholinergics, and low-dose inhaled corticosteroids). Using
a table of randomized numbers, patients were sorted into
two groups: one rMS-treatment (nZ 10) and one control
(nZ 8) group.
Data for both groups (nZ 18) are shown in Table 1 and
demonstrate severe chronic obstruction to the airflow
(mean FEV1: 33.3% (SD: 8.5%) of the predicted value). The
majority of patients were not hypo-nourished according to
the BMI, which was 26.9 kg/m2 (SD: 4.4) in the stimulation
group and 28.3 kg/m2 (SD: 3.9) in the control group,
a difference not reaching clinical significance. Only two
patients in the rMS group were below 21 kg/m2.
Both groups demonstrated slightly reduced values for
muscle strength,24 both for the MVC-Q, which was 32.3 kg
(SD: 14.4) in the rMS group compared to 38.1 kg (SD: 10.5) in
the control group, and for the TwQ, at 7.79 kg (SD: 2.79) in
the rMS group and 8.6 kg (SD: 2) in the control group (n.s.).
Table 1 Characteristics of the trained and control subjects, both at the beginning and at the end of the protocol.
rMS
nZ 10
Final Control
nZ 8
Final Inter-group p
at baseline
Age (years) 61 (6) 62 (8) 0.79
FEV1 (% pred.) 30 (7) 31 (7) 35 (8) 35 (9) 0.1
FEV1/FVC (%) 32 (8) 31 (9) 37 (8) 37 (10) 0.43
BMI (kg/m2) 25.3 (3.8) 25.3 (4.2) 28.33 (4) 27.9 (4) 0.08
FFMI (kg/m2) 18 (3.3) 17.9 (3.7) 19.5 (2.3) 19.3 (2.7) 0.3
MVC-Q (kg) 32 (14) 38 (18)* 38.12(10.5) 44 (13) 0.4
MVC-Q/weight 0.455 (0.2) 0.529 (0.2)* 0.53 (0.2) 0.605 (0.2) 0.4
TwQ (kg) 7.8 (2.8) 8.8 (2.3) 8.6 (2) 9.8 (2.2) 0.5
Endurance time 331 (317) 489 (356) 456 (217) 506 (215) 0.4
6MWT (m) 397 (138) 420 (144)* 420.6 (80) 417.5 (65) 0.7
6MWT (pred.) 75.3% 79.7%* 85.2% 84.5% 0.2
Data given as ‘‘mean (standard deviation)’’. No significant differences found between rMS and control groups, as shown in the last
column. * indicates p< 0.05 between initial and final measurements.
Abbreviations: BMI, body-mass index; FFMI, fat-free mass index; MVC-Q, maximal voluntary contraction of the quadriceps;
TwQ, quadriceps twitch strength.
Predicted values for 6MWT according to Enright.32
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75.2% of the predicted value25 in the rMS group compared
to 420 m (SD: 80), 87.7% of the predicted value in the
controls. The p values resulting from the inter-group
comparison are displayed in Table 1.
Study design and procedures
A diagram of the study design is provided in Fig. 1. All 18
patients received information about the investigation, the
procedures that would be carried out and their risks, and
provided written consent, as approved by the Cruces
Hospital Ethics and Clinical Trials Committee. Regarding
outcomes evaluations, all patients were subjected to
identical assessments and functional procedures.Respiratory function
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Figure 1 Diagram representing the repetitive magnetic neuromu
placement of the stimulation coil on the upper third of the thigh.Evaluation for inclusion included performing clinical
anamnesis and physical exam, evaluation of chest X-ray and
general blood exam and biochemistry, including creatine
kinase (CK) and lactic dehydrogenase (LD). The following
measurements were taken both during the week before the
start of stimulation treatment and in the five days following
its completion:
Pulmonary function tests
Health-related quality of life, using the SF3626 and the
Saint George Respiratory Questionnaire (SGRQ),27 both self-
administered.
Body composition: fat-free mass (FFM) was determined
using the bioelectric impedance method28 (Bodystat-500;
Bodystat Ltd, Douglas, UK) and expressed as a fat-free mass group
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scular stimulation protocol, including a demonstration of the
240 V. Bustamante et al.index (FFMI), which is the result of FFM/(height)2, height
expressed in meters.29
Peripheral muscle function: unpotentiated quadriceps
twitch (TwQ) was measured on both limbs with a Magstim
200 electromagnet, after a prior 20-minute rest period and
observing the protocol and patient position according to the
technique described by Polkey.8 The Biopac dynamometer
(TSD 121C) signal was amplified via a Biopac system (Biopac
System, La Jolla CA, USA), sent to a PC and processed using
previously calibrated digital polygraphy AcqKnowledge
software.
Maximal voluntary contraction of the quadriceps (MVC-
Q) was measured using five maximum isometric contraction
efforts (knee-extension attempts) using the same couch
and patient position as for the TwQ.
QTlim or endurance test: performed according to the
Coronell method,30 the endurance parameter being the
maximum sustainable time for leg extensions of the domi-
nant leg while bearing 10% of the weight of the MVC-Q. The
test started after at least 15 min rest, in an identical
posture to MVC-Q testing. The rotational adjustment and
the angle of the knee were similar in all patients. The
contraction pattern was set to 12 contractions per minute
with a load of 10% of the MVC-Q, allowing two seconds’
contraction and three seconds’ relaxation; the rhythm was
regulated by an audio-digital signal (Joggler Plus 4.8.1;
Leepoware, San Jose´, CA, USA). End of testing was deter-
mined according to Coronell’s criteria.30
Six-minute walking test (6MWT): This test was always
carried out over the same 30 m stretch, according to the
described procedure.31 A minimum of three measurements
was carried out in the initial assessment and two during
post-protocol evaluation.
rMS training protocol: training sessions were started
between one and two weeks after the initial assessment.
Patients in the rMs group were subjected to repetitive
magnetic stimulation in sessions of 15 min on each thigh,
three days per week, for a period of eight weeks. The
assessment was repeated in the five days following the end
of this period.
Stimulation: repetitive magnetic stimulation training of
the quadriceps, rMS, was carried out using a MEDTRONIC
Magpro MCF125 electromagnet with a refrigerated circular
coil of 60 mm radius, applied at the point between the
upper third and the lower two-thirds of the vastus lateralis,
the optimum location for eliciting a contraction response,
as determined by our volunteer validation study.21 Patients
were in a sitting or recumbent position with the knee flexed
at 90and the ankle fixed by a strap as seen in Fig. 1.
The intensity and frequency of stimulation were
adjusted according to the patient’s tolerance and the
performance of the equipment. Stimulation followed
a cyclical pattern of two seconds ON, with contraction
elicited by a burst of twitches, and four seconds OFF,
repeated over a period of 15 min on each thigh. With the
coil being cooled in advance to 5 C, it was possible to
maintain an initial intensity of 40% of the equipment’s
maximum stimulation capacity (2 T) at 15 Hz (stimulus per
second), ending the protocol at an intensity of 70% at 7 Hz.
Since preventing patient discomfort was a major concern,
the intensity was increased by 2e3% every two sessions, on
the condition that the patient had not reported paincaused by the stimulation or unpleasant sensations
following the previous session. In these cases patients were
examined and blood samples were submitted to determine
CK and LD.
Control group: patients received two check-up visits and
one telephone call per week (a total of three contacts per
week), during which they were actively asked about
respiratory symptoms. Physical activity was recommended,
but no repetitive magnetic stimulation at any intensity was
given.
Additional information is available in a Supplementary
file online.
Statistical analysis
The nonparametric ManneWhitney test was used for
comparison between groups, while Wilcoxon’s test for
paired data was chosen to evaluate the effects of the
(training or control) intervention within each group.
Comparison of the inter-group differences was achieved by
comparing the percentage change per variable. Correla-
tions between variables were analysed using Spearman’s
nonparametric coefficient. Statistical significance was
taken as p< 0.05. The 95% confidence interval (CI) was
calculated between the differences in measurement, basal
condition and following treatment in the different groups.
Results
Tolerance of rMS sessions
It was possible to complete the stimulation sessions
satisfactorily in all patients with the intended increases
in intensity, reaching the limit of 70%, pre-established as
the maximum stimulus based on the availability of coils
and refrigeration periods. It was also possible to achieve
the minimal increase of 3% every two sessions, with only
mild muscle soreness reported occasionally by patients.
These symptoms did not persist and no analytical varia-
tions in muscular enzymes (CK and LD) were observed in
anyone. Patients were compliant with the treatment
sessions, fulfilling the schedule, both in rMS and control
groups.
Outcomes of the rMS group compared to the control
group
Pulmonary function and body composition
No significant changes occurred to these parameters in
either group.
Muscle strength parameters
The changes in muscle function, in terms of maximal
voluntary manoeuvres, supramaximal twitch and endurance
are reflected in Fig. 2. After the eight weeks of the inves-
tigation, MVC-Q increased in both groups, by 17.5% (95%
confidence interval (CI): 6.7%; 27.6%) in the rMS group
(pZ 0.005) compared to 15.7% (CI: 0%; 30%) in the control
group (pZ 0.06). The TwQ also increased, but in a non-
significant manner, by 15.6% (CI: 5%; 29%) compared to
14.3% (CI: 6%; 34%).
Changes in quadriceps
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Figure 2 Changes in muscle function: parameter values represented as columns and SD bars. Upper section: Changes in
maximal voluntary contraction of the quadriceps (MVC-Q) and supramaximal twitch values (TwQ) between the start (black column)
and the end (grey column) of the investigation, both for rMS (left panel) and control (right panel) groups. Lower section: changes in
quadriceps endurance over time for both groups, showing mean changes between the start (black) and end (grey) of the study
period.
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With regard to muscle endurance, the time that the load
was able to be supported in the stimulated group increased
by 44% (CI: 1%: 97%), from 331 to 489 seconds (pZ 0.05),
compared to an 11% (CI: 30%: 51%) increase in the control
group (from 456 to 506 s; pZ 0.548), represented in the
lower graph of Fig. 2.
Exercise capacity
The changes in the six-minute walking test for both groups
are displayed in Fig. 3, which shows that the distance
covered changed only in the rMS group, with an increase of
23.4 m (CI: 11; 36), compared to a minimal change of 6 m
(CI: 18; 24) in the control group.
Health-related quality of life
The results of both groups for the general SF36 question-
naire and the specific Saint George Respiratory Question-
naire (SGRQ) are reflected in Fig. 4.
At the start of the study no inter-group differences were
found in quality of life using either of the questionnaires. As
can be observed in Fig. 4, following the rMS training,
decreases in score were greater in all areas of the SGRQ and
the increases in the SF36 were greater and more significant.
While quality of life improved for both groups, the greater
differences for the rMS group are worthy of note, and are
particularly accentuated in the physical function areas of
the SF36 (‘‘physical functioning’’ and ‘‘role limitations due
to physical problems’’). In these two areas the differences
for the rMS group were þ26 (CI: 10; 36) and þ40 (CI: 12; 68)compared to the non-significant changes in the control
group. The ‘‘energy/vitality’’ area showed a mean 17.5
point increase (CI: 0.5; 35), compared to 3.15 (CI: 5; 11) in
the non-trained subjects. In the SGRQ the greatest differ-
ence was visible in the ‘‘activity’’ area, with a decrease of
19.4 (CI: 4; 35) compared to 15 (CI: 5; 26) in
controls. Impact of disease improved after training by
17.5 (CI: 7; 29), but worsened slightly in controls: þ5.7
(CI: 7; 17).
Discussion
Study contributions
This is the first study to use a magnetic stimulating device
for repetitive neuromuscular stimulation of the quadriceps
for the purpose of rehabilitation in COPD patients. It has
demonstrated the applicability of the technique and that it
causes positive outcomes in areas such as effort capacity
and quality of life, which impact on patients’ functional
capabilities that are important for prognosis.32
The design of a protocol for repetitive neuromuscular
stimulation of the quadriceps using a magnetic stimulating
device was based, on the one hand, on data gathered from
assessing the Medtronic equipment on volunteers21 and, on
the other hand, on previous investigations that incorporate
electrical stimulation therapy into traditional respiratory
rehabilitation programmes.9,12e16 These protocols were
adapted, in duration and intensity, to the technical
Changes in six minutes walking distance (6MWD)
p: 0.02 p: 0.7
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Figure 3 On the left, mean changes for each group on the left for the six-minute walking test, between the start (black) and end
(grey) of the protocol, shown as columns and SD bars. On the right, initial and final values for the individual patients in both
groups.
242 V. Bustamante et al.capacities of our Medtronic stimulation equipment, in order
to introduce this innovative method, which is hypotheti-
cally at least as effective as electrical stimulation, into the
rehabilitation context.9
Reasons backing up the technique
Transcutaneous electrical stimulation studies have
consistently demonstrated effectiveness in decreasing
dyspnoea and increasing muscle strength, effort
capacity,15,16 and maximum O2 consumption in stable,
moderate-to-severe COPD patients.17 A systematic
review of studies by Roig12 indicates that more severe
patients show greater benefits after treatment. Its use
during convalescence from acute episodes or critical
conditions involving mechanical ventilation and pro-
longed periods confined to bed has been shown to
prevent functional deterioration and to shorten recovery
time.13,14
Despite various authors18,19 reporting that there may be
limitations to performing muscle training via electrical
stimulation in specific subjects, sufficient experience has
arisen to indicate that this is a feasible treatment option in
COPD and heart-failure patients. We have here considered
repetitive magnetic neuromuscular stimulation as another
option that could potentially have at least similar tolera-
bility and effects.
The idea arose after testing a Medtronic electromagnet
on the thigh, which elicited a contraction response equiv-
alent to 80% of supramaximal femoral twitch, with high
reproducibility and a ceiling of response.21 It seemed
consistent with these findings that muscle contractions
caused by repeated magnetic stimuli encompassing large,
deep muscle-sections should have a training effect, thus
opening up new treatment possibilities.One limitation of stimulating devices, despite the
refrigerated coils, is the thermogenic effect of the high-
intensity electrical currents running through them. Conse-
quently, the maximum stimulus frequency was adjusted
between 15 and 7 Hz, in order to complete the study with
increasing stimulus intensity. Despite these frequency
adaptations, the visible contraction response increased in
parallel with the intensity, probably due to a known facil-
itation effect.7
Proven outcomes
In the stimulated patients, a 5.55 kg increase of voluntary
strength in the quadriceps was found, a 17.5% increase in
MVC-Q, similar to that which has been observed using
electrical stimulation in patients with substantial muscular
deterioration,15 in particular, following critical situations or
acute episodes.13,14 The literature states that strength
training seems to provide little benefit when added to
exercise-based rehabilitation programmes.33 This is true
when the benefits are evaluated using general exercise
parameters, but not in terms of quality of life, to which
these methods make significant changes.33,34
The stimulated patients in this study showed significant
increases in endurance time, with a mean increase of 158 s
per patient, much greater than the 48-s increase recorded
in the control group. The fact that the differences were
greater for endurance than for muscle strength, suggests
that this procedure might constitute a type of ‘‘endurance
training’’ and although magnetic and electrical stimulation
concepts might not be interchangeable, the outcome
profile for our protocol would seem to be more similar to
that of low-frequency than high-frequency electrical stim-
ulation.35 Previous data on redox status and fibre-type
changes support this interpretation, as muscle oxidative
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Figure 4 Changes in the quality-of-life tests, for the SGRQ (above) and the SF36 (below), represented as mean scores SD. SGRQ:
For the rMS group, all four areas (* p< 0.05) improved significantly (symptoms, activities, impact and total) and for the control
group: symptoms, activity and total, in a smaller degree. SF36: changes in the QOL scores are shown in this order: physical
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Muscle training with repetitive magnetic stimulation 243stress was not enhanced, while the size of slow-twitch
fibres increased.22
The observed outcome with regard to exercise capacity
following eight weeks of training with magnetic stimulation
was a mean increase of 23.4 m in the distance walked over
six minutes, performed according to standard practice.31
This increase was seen in almost all patients and does not
appear attributable to a learning effect, since it was not
observed in the control group. While a ‘‘threshold of clin-
ical significance’’ of 54 m has been set in the literature,36
based on quality-of-life changes for patients, in our opinion
it appears promising that an approach other than specific
exercise training should display an effect, however small,
on exercise capacity. To back up this line of thought, the
combined effect of electrical stimulation with exercise
training achieved a positive gain of 63 m in the six-minute
walking test, compared to the 30 m achieved by the stan-
dard rehabilitation treatment,13 suggesting that muscle
stimulation can increase the benefits of respiratory reha-
bilitation. It has been documented for electrical stimula-
tion that ‘‘weaker’’ patients do improve most after musclestimulation,12 this being the reason to be concerned by the
fact that our rMS group patients showed slightly lower
6MWD and BMI values at baseline, a circumstance that
could explain the greater benefit they might have received
from any intervention.
Parallel monitoring of both groups leads us to attribute
changes in quality-of-life questionnaires in non-rMS
patients to a placebo effect, most evident in general health
perception and changes over time in the SF36 and in all
areas of the SGRQ except in that of ‘‘impact of the
disease’’. Nevertheless, the magnitude of the changes was
greater in the rMS group for all areas of the SGRQ and in the
areas of the SF36 related to physical functioning, role
limitation due to physical problems, vitality and social
functioning. These changes in physical function, both in the
sphere of symptoms and of impact of the illness, are those
that might be related to the effects of magnetic stimula-
tion. Similarly, with electrical stimulation, other authors
have found general improvements in quality of life,
particularly related to dyspnoea, not observed in the
control patients.13,15
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Unlike the application of surface electrodes for electrical
stimulation, there is a lack of prior experience with
magnetic stimulation used outside of the diagnostic sphere.
The fundamental interest in trialling this method resides in
the improved tolerance hypothesis, but the novelty,
complexity and high cost of stimulating devices mean that
general experience in handling this equipment is extremely
limited, for which reason our initial investigation had to be
staged at a rather basic level.21 After achieving some
experience with the technique, we felt confident to apply it
to patients in a pilot study such as the present one, in order
to document changes in the main areas in which the
effectiveness of exercise-based rehabilitation treatment in
COPD patients has been reported.9
While the feasibility and tolerance of the trialled stim-
ulation protocol have been proven, it has still not been
determined which are the optimum intensity, frequency
and stimulation duration sequences (depending on the
available equipment, including the quantity and sophisti-
cation of the coils) and which patients could benefit most
from this treatment, whether in combination with tradi-
tional rehabilitation, or not.
Conclusions
An rMS programme has demonstrated improvements in
muscle function parameters, effort capacity and quality of
life in severe COPD patients.
It can be postulated that this stimulation method might
be an alternative for patients incapable of engaging in
conventional rehabilitation exercise. It is also a well-
tolerated, promising option for patients debilitated due to
an intercurrent acute disease, bedridden or in intensive
care units, in which respiratory rehabilitation is not
appropriate or may even have negative effects.
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